Intelligent Living, Inc. (OTCMKTS:ILIV) Bucks Falling Trend on Corporate Update
Intelligent Living, Inc. (OTCMKTS:ILIV) has been fighting to keep the initial gains it made when it shot up as a new addition to the set of marijuana stocks. ILIV grew by more than 26% on Wednesday, reaching $0.0115, on dollar volumes above $1.05 million. 
The company increased interest with an interim corporate update from February 25th, and thus managed to break the downward trend that was forming in the past week. ILIV posted an explanation of its holding structure, including its several core activities- Mobile and Gaming, Wellness Products and Services and Healthcare and IT Cloud Services. For now, there are no more updates on how ILIV would integrate medical cannabis into its business model.
The company plans to release several mobile games for GooglePlay, Apple iOS and other platforms. ILIV recently released an Android app for medication planning, but it still looks like a derivative product with little potential for competitive advantage. Added to this mix of electronic services is a consultation website that also sells herbal supplements.
Unfortunately, ILIV has not managed well in reporting the contributions of the various businesses. The latest balance sheet data are from 2012, and the last quarters of 2013 show significant limitations. ILIV has revealed:
- $11,000 cash as of 2012
- $665,000 total current liabilities
- Zero revenues for the second and third quarter of 2013
- $4.19 million net loss for the quarter ended September 30th
As it is easily seen, the widespread holding may be rather active, but at least when it comes to reporting results, the filings contain enough disappointments. Despite the fundamental gaps of this company, and the tenuous relationship to the cannabis sector, investors’ forums seem to be enjoying the ride for short-term gains potential, including some technical analysis. At a price of one cent, ILIV is still underpriced enough to continue with surprising days of significant gains.
ILIV tried to present itself as a company devoted to health and wellness, and thus seeking a path in the business of medical cannabis. This was also the choice of several other penny stocks, as for some the move proved a real success. Perhaps the biggest success story remains that of Creative Edge Nutrition, Inc. (OTCMKTS:FITX), which started from double-zero positions and on the right momentum, managed to touch the ten-cent levels. Now, FITX has retreated a little, but remains more actively traded than in the past.
Easton Pharmaceuticals, Inc. (OTCMKTS:EAPH) also started off at $0.0025, but on the right mix of news and momentum is so far hanging around the $0.05 levels. EAPH has enough red flags as well, being a former stem cell company and trying to sell a single, non-FRA approved cosmetic product, while claiming a status as a pharmaceutical researcher and producer. We are yet to wait and see if EAPH produces a viable medical cannabis product.
If you like ILIV or other similar cases, it is still best to decide on the preferred time frame, and be aware that lasting momentum is not always the case.
